GL1X · GenesisL1 explorer

MolNFT v1 · #166060 · protein + DNA

Structure of tbp bound to C-C mismatch containing tata site

6UEQ · Tata-box-binding protein 1: “Structure of tbp bound to C-C mismatch containing tata site”. X-ray diffraction, 1 ligand (SO4), 1 pocket (best druggability 0.40). MolNFT v1 #166060 on GenesisL1: 3D structure, binding sites and pockets…

PDB
6UEQ
Type
protein + DNA
Length
215 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tata-box-binding protein 1; DNA (5'-D(*GP*CP*TP*AP*TP*AP*AP*AP*AP*CP*GP*GP*CP*A)-3'); DNA…
UniProt
P28147
Ligands
SO4
Pockets
1 · best druggability 0.40

Structure

x-ray diffraction · 3 distinct chains · 26% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BTata-box-binding protein 1protein18726% helix, 35% strandP28147
CDNA (5'-D(*GP*CP*TP*AP*TP*AP*AP*AP*AP*CP*GP*GP*CP*A)-3')dna14——
DDNA (5'-D(*TP*GP*CP*CP*CP*TP*TP*TP*TP*AP*TP*AP*GP*C)-3')dna14——

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11850.400.7222SO4

Interfaces

3 interfaces between chains.

  • B–D · 856 Ų buried · 10 hydrogen bonds · protein-nucleic
  • B–C · 837 Ų buried · 6 hydrogen bonds · protein-nucleic
  • C–D · 616 Ų buried · 58 hydrogen bonds · nucleic-nucleic

Compared structures

  • 6UEQ · Structure of TBP bound to C-C mismatch containing TATA site · the same entry in another collection · chain C against C, TM-score 1.00
  • P28147 · AlphaFold monomer V2.0 prediction for tata-box-binding protein 1 (P28147) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.